annual net income:
$444.09M+$162.50M(+57.71%)Summary
- As of today (June 22, 2025), HALO annual net profit is $444.09 million, with the most recent change of +$162.50 million (+57.71%) on December 31, 2024.
- During the last 3 years, HALO annual net income has risen by +$41.38 million (+10.28%).
- HALO annual net income is now at all-time high.
Performance
HALO Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$118.09M-$18.92M(-13.81%)Summary
- As of today (June 22, 2025), HALO quarterly net profit is $118.09 million, with the most recent change of -$18.92 million (-13.81%) on March 31, 2025.
- Over the past year, HALO quarterly net income has increased by +$41.27 million (+53.72%).
- HALO quarterly net income is now -45.47% below its all-time high of $216.59 million, reached on September 30, 2021.
Performance
HALO quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
$485.36M+$41.27M(+9.29%)Summary
- As of today (June 22, 2025), HALO TTM net profit is $485.36 million, with the most recent change of +$41.27 million (+9.29%) on March 31, 2025.
- Over the past year, HALO TTM net income has increased by +$166.56 million (+52.25%).
- HALO TTM net income is now at all-time high.
Performance
HALO TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
HALO Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.7% | +53.7% | +52.3% |
| 3 y3 years | +10.3% | +96.5% | +11.6% |
| 5 y5 years | +714.7% | +2035.0% | +705.6% |
HALO Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.7% | -13.8% | +420.6% | at high | +167.2% |
| 5 y | 5-year | at high | +714.7% | -45.5% | +2035.0% | at high | +705.6% |
| alltime | all time | at high | +531.1% | -45.5% | +443.3% | at high | +504.5% |
HALO Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $118.09M(-13.8%) | $485.36M(+9.3%) |
| Dec 2024 | $444.09M(+57.7%) | $137.01M(+0.0%) | $444.09M(+13.2%) |
| Sep 2024 | - | $137.01M(+46.9%) | $392.47M(+16.4%) |
| Jun 2024 | - | $93.25M(+21.4%) | $337.29M(+5.8%) |
| Mar 2024 | - | $76.82M(-10.0%) | $318.80M(+13.2%) |
| Dec 2023 | $281.59M(+39.3%) | $85.39M(+4.3%) | $281.59M(+10.9%) |
| Sep 2023 | - | $81.84M(+9.5%) | $253.91M(+8.6%) |
| Jun 2023 | - | $74.75M(+88.7%) | $233.71M(+28.7%) |
| Mar 2023 | - | $39.62M(-31.3%) | $181.64M(-10.1%) |
| Dec 2022 | $202.13M(-49.8%) | $57.70M(-6.4%) | $202.13M(-4.3%) |
| Sep 2022 | - | $61.63M(+171.7%) | $211.20M(-42.3%) |
| Jun 2022 | - | $22.68M(-62.3%) | $366.15M(-15.8%) |
| Mar 2022 | - | $60.11M(-10.0%) | $434.92M(+8.0%) |
| Dec 2021 | $402.71M(+212.0%) | $66.77M(-69.2%) | $402.71M(-1.6%) |
| Sep 2021 | - | $216.59M(+136.8%) | $409.10M(+78.9%) |
| Jun 2021 | - | $91.46M(+227.9%) | $228.72M(+40.3%) |
| Mar 2021 | - | $27.89M(-61.9%) | $163.08M(+26.3%) |
| Dec 2020 | $129.09M(-278.7%) | $73.16M(+102.1%) | $129.09M(+499.7%) |
| Sep 2020 | - | $36.21M(+40.2%) | $21.52M(-154.2%) |
| Jun 2020 | - | $25.82M(-523.0%) | -$39.70M(-50.5%) |
| Mar 2020 | - | -$6.10M(-82.3%) | -$80.14M(+10.9%) |
| Dec 2019 | -$72.24M(-10.1%) | -$34.40M(+37.5%) | -$72.24M(+80.7%) |
| Sep 2019 | - | -$25.02M(+71.1%) | -$39.97M(-6.6%) |
| Jun 2019 | - | -$14.62M(-914.3%) | -$42.80M(-16.2%) |
| Mar 2019 | - | $1.80M(-184.5%) | -$51.07M(-36.4%) |
| Dec 2018 | -$80.33M(-227.6%) | -$2.13M(-92.4%) | -$80.33M(-275.9%) |
| Sep 2018 | - | -$27.85M(+21.7%) | $45.68M(-40.1%) |
| Jun 2018 | - | -$22.89M(-16.6%) | $76.28M(+11.5%) |
| Mar 2018 | - | -$27.46M(-122.2%) | $68.41M(+8.6%) |
| Dec 2017 | $62.97M(-161.1%) | $123.88M(+4406.4%) | $62.97M(-171.3%) |
| Sep 2017 | - | $2.75M(-108.9%) | -$88.30M(-26.4%) |
| Jun 2017 | - | -$30.76M(-6.5%) | -$119.99M(+3.3%) |
| Mar 2017 | - | -$32.90M(+20.1%) | -$116.10M(+12.7%) |
| Dec 2016 | -$103.02M(+219.6%) | -$27.39M(-5.4%) | -$103.02M(+44.5%) |
| Sep 2016 | - | -$28.95M(+7.7%) | -$71.32M(+6.7%) |
| Jun 2016 | - | -$26.88M(+35.6%) | -$66.83M(+80.9%) |
| Mar 2016 | - | -$19.82M(-558.9%) | -$36.94M(+14.6%) |
| Dec 2015 | -$32.23M(-52.9%) | $4.32M(-117.7%) | -$32.23M(-22.9%) |
| Sep 2015 | - | -$24.46M(-910.2%) | -$41.82M(+11.1%) |
| Jun 2015 | - | $3.02M(-120.0%) | -$37.64M(-33.9%) |
| Mar 2015 | - | -$15.11M(+186.5%) | -$56.94M(-16.7%) |
| Dec 2014 | -$68.38M(-18.1%) | -$5.27M(-74.0%) | -$68.38M(-19.6%) |
| Sep 2014 | - | -$20.28M(+24.6%) | -$85.09M(+1.2%) |
| Jun 2014 | - | -$16.27M(-38.7%) | -$84.10M(-7.3%) |
| Mar 2014 | - | -$26.55M(+20.7%) | -$90.74M(+8.7%) |
| Dec 2013 | -$83.48M | -$21.99M(+14.0%) | -$83.48M(+26.7%) |
| Sep 2013 | - | -$19.29M(-15.8%) | -$65.90M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | -$22.91M(+18.8%) | -$66.61M(+15.4%) |
| Mar 2013 | - | -$19.29M(+337.8%) | -$57.72M(+7.8%) |
| Dec 2012 | -$53.55M(+170.9%) | -$4.41M(-78.0%) | -$53.55M(-20.7%) |
| Sep 2012 | - | -$20.01M(+42.7%) | -$67.56M(+59.4%) |
| Jun 2012 | - | -$14.02M(-7.3%) | -$42.39M(+67.9%) |
| Mar 2012 | - | -$15.12M(-17.9%) | -$25.25M(+27.7%) |
| Dec 2011 | -$19.77M(-62.9%) | -$18.42M(-456.5%) | -$19.77M(+8.3%) |
| Sep 2011 | - | $5.17M(+65.7%) | -$18.25M(-49.1%) |
| Jun 2011 | - | $3.12M(-132.3%) | -$35.82M(-29.9%) |
| Mar 2011 | - | -$9.64M(-43.0%) | -$51.09M(-4.0%) |
| Dec 2010 | -$53.24M(-8.8%) | -$16.89M(+36.1%) | -$53.24M(+8.6%) |
| Sep 2010 | - | -$12.41M(+2.1%) | -$49.01M(-3.0%) |
| Jun 2010 | - | -$12.15M(+3.1%) | -$50.51M(-8.9%) |
| Mar 2010 | - | -$11.79M(-6.9%) | -$55.42M(-5.0%) |
| Dec 2009 | -$58.36M(+19.9%) | -$12.66M(-9.0%) | -$58.36M(-6.7%) |
| Sep 2009 | - | -$13.91M(-18.5%) | -$62.52M(+5.1%) |
| Jun 2009 | - | -$17.06M(+15.9%) | -$59.48M(+11.3%) |
| Mar 2009 | - | -$14.73M(-12.5%) | -$53.43M(+9.8%) |
| Dec 2008 | -$48.65M(+103.6%) | -$16.83M(+54.8%) | -$48.65M(+20.0%) |
| Sep 2008 | - | -$10.87M(-1.2%) | -$40.54M(+10.5%) |
| Jun 2008 | - | -$11.00M(+10.5%) | -$36.69M(+20.3%) |
| Mar 2008 | - | -$9.95M(+14.3%) | -$30.49M(+27.6%) |
| Dec 2007 | -$23.90M(+62.0%) | -$8.71M(+23.9%) | -$23.90M(+22.1%) |
| Sep 2007 | - | -$7.03M(+46.4%) | -$19.57M(+20.9%) |
| Jun 2007 | - | -$4.80M(+43.0%) | -$16.19M(+10.7%) |
| Mar 2007 | - | -$3.36M(-23.3%) | -$14.62M(-0.9%) |
| Dec 2006 | -$14.75M(+11.1%) | -$4.38M(+19.9%) | -$14.75M(+6.2%) |
| Sep 2006 | - | -$3.65M(+12.9%) | -$13.89M(-0.4%) |
| Jun 2006 | - | -$3.23M(-7.4%) | -$13.94M(+2.7%) |
| Mar 2006 | - | -$3.49M(-0.7%) | -$13.57M(+2.2%) |
| Dec 2005 | -$13.28M(+46.0%) | -$3.51M(-5.1%) | -$13.28M(+8.5%) |
| Sep 2005 | - | -$3.70M(+29.0%) | -$12.24M(+3.8%) |
| Jun 2005 | - | -$2.87M(-10.2%) | -$11.79M(+7.2%) |
| Mar 2005 | - | -$3.19M(+28.8%) | -$11.00M(+21.0%) |
| Dec 2004 | -$9.09M(+329.9%) | -$2.48M(-23.8%) | -$9.09M(+19.4%) |
| Sep 2004 | - | -$3.25M(+56.8%) | -$7.61M(+58.6%) |
| Jun 2004 | - | -$2.07M(+61.5%) | -$4.80M(+53.4%) |
| Mar 2004 | - | -$1.28M(+28.2%) | -$3.13M(+47.9%) |
| Dec 2003 | -$2.12M(+86.4%) | -$1.00M(+128.1%) | -$2.12M(-5.1%) |
| Sep 2003 | - | -$439.00K(+8.9%) | -$2.23M(+23.7%) |
| Jun 2003 | - | -$403.00K(+48.4%) | -$1.80M(+27.3%) |
| Mar 2003 | - | -$271.50K(-75.7%) | -$1.42M(+24.8%) |
| Dec 2002 | -$1.13M(+2758.4%) | -$1.12M(+8752.4%) | -$1.13M(+5779.3%) |
| Sep 2002 | - | -$12.60K(-21.7%) | -$19.30K(+188.1%) |
| Jun 2002 | - | -$16.10K(-271.3%) | -$6700.00(-171.3%) |
| Mar 2002 | - | $9400.00 | $9400.00 |
| Dec 2001 | -$39.70K | - | - |
FAQ
- What is Halozyme Therapeutics annual net profit?
- What is the all time high annual net income for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual net income year-on-year change?
- What is Halozyme Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly net income year-on-year change?
- What is Halozyme Therapeutics TTM net profit?
- What is the all time high TTM net income for Halozyme Therapeutics?
- What is Halozyme Therapeutics TTM net income year-on-year change?
What is Halozyme Therapeutics annual net profit?
The current annual net income of HALO is $444.09M
What is the all time high annual net income for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual net profit is $444.09M
What is Halozyme Therapeutics annual net income year-on-year change?
Over the past year, HALO annual net profit has changed by +$162.50M (+57.71%)
What is Halozyme Therapeutics quarterly net profit?
The current quarterly net income of HALO is $118.09M
What is the all time high quarterly net income for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly net profit is $216.59M
What is Halozyme Therapeutics quarterly net income year-on-year change?
Over the past year, HALO quarterly net profit has changed by +$41.27M (+53.72%)
What is Halozyme Therapeutics TTM net profit?
The current TTM net income of HALO is $485.36M
What is the all time high TTM net income for Halozyme Therapeutics?
Halozyme Therapeutics all-time high TTM net profit is $485.36M
What is Halozyme Therapeutics TTM net income year-on-year change?
Over the past year, HALO TTM net profit has changed by +$166.56M (+52.25%)